Fate Therapeutics (FATE)
(Delayed Data from NSDQ)
$1.21 USD
0.00 (0.00%)
Updated Oct 3, 2025 04:00 PM ET
After-Market: $1.22 +0.01 (0.83%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth C Momentum D VGM
Fundamental Charts
About Dividend Yield (TTM)
Fate Therapeutics, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
FATE 1.21 0.00(0.00%)
Will FATE be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for FATE based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for FATE
Fate Therapeutics (FATE) Reports Q2 Loss, Beats Revenue Estimates
Enanta Pharmaceuticals (ENTA) Reports Q3 Loss, Tops Revenue Estimates
FATE: What are Zacks experts saying now?
Zacks Private Portfolio Services
Health Catalyst (HCAT) Q2 Earnings and Revenues Beat Estimates
Viridian Therapeutics, Inc. (VRDN) Reports Q2 Loss, Misses Revenue Estimates
Why Is Fate Therapeutics (FATE) Up 61.5% Since Last Earnings Report?
Other News for FATE
FATE forms 200 Day Moving Average Support on October 3
200 Day Moving Average Support appears for FATE after 4.8% move
FATE forms 200 Day Moving Average Support on October 1
Is FATE showing upside potential? Crossed Above 50 Day Moving Average shows up after rocketing 26.0%
12 Health Care Stocks Moving In Tuesday's Intraday Session